Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

Summary

The purpose of this study was to evaluate the antibody response to each of the four influenza vaccine strains included in the study vaccine, as measured by hemagglutination inhibition (HAI) at 4 weeks after the last dose of the study vaccine in young subjects aged between 3 years old and 17 years old.

Timeline

Start

2016-12-28

Primary completion

2017-07-12

Completion

2017-12-27

Drugs

Indications